Agreement addresses all requests by President Trump to reduce drug costs in the U.S., encourage global investment and protect ...
Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...
Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a ...
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite holding FDA Orphan Drug Designations, passing multiple DEA inspections, being awarded a DEA ...
Boards and executive buyers are raising the 2026 bar for all product and service rankings and this annual statement explains the standards Black Book applies to keep survey evaluations rigorous, ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...
Global Cellular Health Screening Market OverviewThe global cellular health screening market was valued at approximately US$ 2 ...
Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care.NEW ...
CHICAGO, IL / ACCESS Newswire / December 19, 2025 / For a long stretch, Cosmos Health (NASDAQ:COSM) sat in a familiar category. A company investors respected, followed, and occasionally revisited, but ...
STOCKHOLM, SE / ACCESS Newswire / December 19, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results